Matinas BioPharma Holdings (MTNB) Other Operating Expenses (2013 - 2024)
Matinas BioPharma Holdings (MTNB) reported Other Operating Expenses of $4.4 million for Q4 2024, up 29640.0% quarter-over-quarter from -$15000.0 in Q4 2021.
Matinas BioPharma Holdings (MTNB) Other Operating Expenses (2013 - 2024) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 7 years of Other Operating Expenses data on file, last reported at $4.4 million in Q4 2024.
- Other Operating Expenses for Q4 2024 came in at $4.4 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $4.4 million (changed N/A YoY), and the FY2024 annual result was $4.4 million, changed N/A from the prior year.
- Other Operating Expenses rose to $4.4 million in Q4 2024 per MTNB's latest filing, from -$15000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $4.4 million in Q4 2024 and troughed at -$93000.0 in Q2 2020.
- A 3-year average of $449666.7 and a median of -$29000.0 in 2020 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 76.35% in 2020 and fell as far as 58.43% in 2020.
- A 3-year view of Other Operating Expenses shows it stood at -$29000.0 in 2020, then soared by 48.28% to -$15000.0 in 2021, then jumped by 29640.0% to $4.4 million in 2024.
- Business Quant data shows MTNB's Other Operating Expenses at $4.4 million in Q4 2024, -$15000.0 in Q4 2021, and -$29000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2021 | -15,000.00 |
| Sep 30, 2021 | -29,000.00 |
| Jun 30, 2021 | -28,000.00 |
| Mar 31, 2021 | -20,000.00 |
| Dec 31, 2020 | -29,000.00 |
| Sep 30, 2020 | -90,000.00 |
| Jun 30, 2020 | -93,000.00 |
| Mar 31, 2020 | -80,000.00 |
| Dec 31, 2019 | -122,600.00 |
| Sep 30, 2019 | -62,100.00 |
| Jun 30, 2019 | -58,700.00 |
| Mar 31, 2019 | -116,700.00 |
| Sep 30, 2018 | -274,000.00 |
| Jun 30, 2018 | -341,828.00 |
| Mar 31, 2018 | -172.00 |
| Jun 30, 2014 | -5,385.00 |
| Mar 31, 2014 | 9,996.00 |
| Jun 30, 2013 | 57.00 |